We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cooling Newborns Reduces Disability

By HospiMedica staff writers
Posted on 23 Oct 2005
Lowering the body temperature of full-term newborns to about 92oF within the first six hours can reduce the chance of disability and death among infants who do not receive enough oxygen or blood to the brain during birth, according to a new study reported in the October 13, 2005, issue of The New England Journal of Medicine.

When an infant's brain fails to receive sufficient oxygen or blood before birth, hypoxic ischemic encephalopathy (HIE) may occur hours before birth or during labor and delivery. More...
This can be caused by compression of the placenta, tearing of the placenta from the uterine wall before birth, compression of the umbilical cord, or rupture of the uterus. HIE occurs about 0.5 to 1 times every thousand births. According to the study's authors, 10% of infants with moderate HIR die, as do 60% of those with severe HIE.

Prior studies in laboratory animals suggested that cooling the brain from 2-5oC after HIE could reduce death and disability. In the current study, researchers enrolled 208 full-term infants from 15 centers who had experienced oxygen deprivation during birth, assigning them either to a group with experimental cooling or a group receiving standard care. The experimental group infants were cooled by placing them on a soft blanket through which cool water circulated that lowered the temperature of the infants to 92.3oF. They remained on the blanket for 72 hours, and were then gradually warmed to normal body temperature.

When the doctors examined the infants at 18-22 months of age, 44% of those in the cooling group developed moderate to severe disability or died, compared to 62% in the control group.

"Physicians need to exercise extreme caution in putting the study's result into practice,” said Rose Higgins, M.D., program scientist for the U.S. National Institute of Child Health and Human Development (NICHD, Bethesda, MD, USA), which conducted the study. Most newborn intensive care units do not have the resources or personnel to duplicate the conditions of the study, she observed.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.